---
layout: research
title: "Sharda Motor Industries Ltd (SHARDAMOTR) - Comprehensive Stock Research Report"
date: 2025-08-23
permalink: /shardamotr/20250823/
ticker: "SHARDAMOTR"
sector: "Auto Components"
current_price: "₹1,058"
market_cap: "₹6,072 Cr"
recommendation: "BUY"
target_price: "₹1,274 (12 months)"
---

### Company Overview

| Metric | Value |
|--------|-------|
| **Company** | Sharda Motor Industries Ltd (SHARDAMOTR) |
| **Sector** | Auto Components |
| **Current Price** | ₹1,058 |
| **Market Cap** | ₹6,072 Cr |
| **Analysis Date** | 2025-08-23 |

### Industry Overview

- Indian auto-components sector benefits from regulatory-driven content increase (stricter emission norms, TREM‑V/CEV/BS‑VII) and demand for lightweighting (EV & fuel-efficiency), creating multi-year tailwinds for part suppliers.  
- “China+1” supply‑chain re‑shoring (US/EU OEMs) is a material export opportunity for competitive Indian Tier‑1s; company cites an addressable export opportunity (management estimate) for its product set.  
- Sector is cyclical (PV/CV cycles) and exposed to commodity (steel/Al) volatility; EV adoption will structurally re-shape some ICE-related product demand but creates new lightweighting opportunities.  
- Competitive intensity rising as global Tier‑1s localise; technology/IP and backward integration become key differentiation factors.

### Detailed Analysis & Scores

#### Sectoral Analysis: 7/10

| Key Areas | Assessment |
|-----------|------------|
| Industry Growth Rate | ~6-8% p.a. (3-5 yr outlook) |
| Market Size | Large; addressable export pockets (management: USD 2.2bn for current product set) |
| Sector Tailwinds | Emission norms, lightweighting demand, China+1 export shift |
| Sector Headwinds | EV penetration (longer term), OEM volume cyclicality, commodity risk |
| Policy Support | Neutral-to-positive (emission regulations increase content) |
| Competition Level | Medium-High |
| Technology Disruption | Positive for companies with R&D/IP and light‑weighting capabilities |

**Score Reasoning:**  
- Regulatory tightening (BS‑VII/TREM‑V/CEV) materially increases content per vehicle for emission and temperature‑control components — positive structural tailwind.  
- Lightweighting (control arms, suspension) provides a secular growth opportunity tied to EV/CAFE norms.  
- Export opportunity (China+1) is a clear runway but requires execution (certification, qualification cycles).  
- Cyclicality of PV/CV volumes and global geopolitics (tariffs, sourcing shifts) create short‑term unpredictability.  
- Sharda’s product mix (emissions + lightweighting) aligns well with the most attractive sector subsegments.

#### Financial Strength: 9/10

| Financial Metrics | Value | Benchmark |
|-------------------|-------|-----------|
| Debt-to-Equity | 0.05 | <1.5 (Good) |
| Interest Coverage | 94x | >2.5x (Good) |
| Free Cash Flow (FY) | ₹211 Cr (reported) | Positive (Good) |
| Current Ratio | 2.24 | >1.2 (Good) |
| Quick Ratio | 1.91 | >1.0 (Good) |
| Net Liquidity (Cash + Investments - Borrowings) | ~₹906 Cr (approx.) | Higher is better |
| Cash & Equivalents | ₹201 Cr (Mar‑25) | Higher is better |

**Score Reasoning:**  
- Very low leverage; interest coverage is extremely healthy — company can service growth capex and pursue M&A without material refinancing risk.  
- Large cash + liquid investments (several hundred crores) provide strategic optionality for inorganic deals and smooth capital return (dividend/buyback).  
- Operating cash flow is positive and historically strong; FCF generation is consistent.  
- Working capital metrics are efficient (debtor ~37 days, inventory ~36 days, payables ~94 days, cash conversion cycle negative), supporting cash conversion.  
- Key risk: management has returned cash via buyback/dividend; continued aggressive cash returns would reduce headroom for capex/M&A.

#### Valuations: 7/10

| Valuation Metrics | Current | Peer / Median |
|-------------------|---------|---------------|
| P/E (TTM) | 19.1x | Median peers ~27.4x |
| P/BV | 5.63x | Median peers ~3.29x |
| EV/EBITDA | 12.2x | Median peers ~13.7x |
| Market Cap / Sales | 2.14x (6,072 / 2,837) | - |
| Intrinsic Value (analyst model) | ₹1,206 (internal estimate) | - |

**Score Reasoning:**  
- P/E (19x) is below peer median — reflects current earnings power and modest market multiple compared to growth peers.  
- Higher P/B (5.6x) reflects very high ROE/ROCE (ROE ~30%, ROCE ~39%) which justifies premium book valuation.  
- EV/EBITDA is roughly in line with peers — reasonable given the mix of high ROCE and net cash.  
- Valuation appears fair to slightly attractive on earnings basis, expensive on book basis; investor premium contingent on growth delivery (exports, lightweighting).

#### Growth Potential: 8/10

| Key Metrics | Value |
|------------|-------|
| ROE | 29.7% |
| ROCE | 38.7% |
| Revenue Growth (5Y CAGR) | 26.9% |
| Revenue Growth (3Y CAGR) | 7.9% |
| FY25 Revenue | ₹2,837 Cr |
| FY25 PAT | ~₹315 Cr |
| Capex guidance | ₹50-75 Cr (FY26 stated); management also referenced phased capex ~₹250 Cr over multi-year for growth) |
| Dividend Payout | ~29.8% |

**Score Reasoning:**  
- Strong capital efficiency (ROCE/ROE) allows high returns on incremental capital and supports higher valuation if scale is achieved.  
- Historical 5‑year sales CAGR strong; near-term sales (FY25) were muted (+1%) but margins expanded — demonstrates margin resilience and product mix improvement.  
- Multiple growth levers: TREM‑V/CEV/BS‑VII driven content increase, lightweighting (control arms), export order wins (US/EU pipeline) and JV/tech tie‑ups.  
- Execution risk exists (export qualification timelines can be long), but the company has capacity and R&D to convert wins over 12–24 months.

#### Corporate Governance: 8/10

| Management Quality | Assessment |
|-------------------|------------|
| Concall Frequency | Frequent (quarterly + investor presentations) |
| Strategic Vision Clarity | Clear and articulated (exports, lightweighting, JV strategy) |
| Management Communication | High (transparent on orders, capex and cash policy) |
| Governance Score | 8/10 |
| Transparency Rating | High |

| Corporate Actions | Details |
|------------------|---------|
| Dividend Yield | FY25 final dividend ₹32.50/share (generous) |
| Dividend History | Regular dividends in recent years |
| Buyback | Buyback (2024) executed at premium |
| Bonus | 1:1 bonus (2025) |
| Capital Allocation | Active — mix of shareholder returns and reinvestment |

**Score Reasoning:**  
- Management communicates frequently and provides detailed disclosure (presentations, concalls, filings).  
- Shareholder-friendly actions (buyback, healthy dividend, bonus shares) show intent to return value; large cash balance gives credibility.  
- Promoter holding remains high (~64%), no pledging — alignment positive.  
- Execution quality historically good; still need to monitor capital allocation for sustainability (capex vs. returns).

#### Research Reports: 6/10

| Research Metrics | Value |
|------------------|-------|
| Broker Coverage | Limited in public broker PDFs captured |
| Average Target Price (analyst samples) | Internal intrinsic ~₹1,206 |
| Consensus Rating | Mixed to Positive (analyst decks/presentations available) |
| Upside/Downside vs CMP (analyst medians) | Modest upside to intrinsic estimates |

**Score Reasoning:**  
- Company has several investor presentations and concall notes; broker report coverage in public PDFs is limited in our retrieval.  
- Internal analyst intrinsic value around ₹1,206 implies upside but not unanimous consensus.  
- Lack of deep broker coverage constrains the breadth of external checks; presentations and rating‑agency notes (CRISIL) provide the principal external validation.

#### Technical Analysis & Market Sentiments: 7/10

| Period | Return | vs Nifty |
|--------|--------|----------|
| 1 Month | -11% (approx.) | Underperformance vs short-term market moves |
| 3 Month | +8% (approx.) | Modest outperformance |
| 6 Month | +30% (approx.) | Strong recovery / momentum |
| 1 Year | -22% | Underperformed over 12 months (prior drawdown) |

| Technical Indicators | Value |
|---------------------|-------|
| RSI | Not provided (momentum mixed) |
| 50-DMA | ₹1,028 |
| 200-DMA | ₹955 |
| Volume Trend | Episodic spikes (corporate actions, news) |

| Market Sentiment & Near-term Events | Assessment |
|-------------------------------------|------------|
| News Sentiment | Positive (buyback, dividend, export wins) |
| Institutional Interest | Increasing DIIs exposure (~11%) |
| Options Activity | Not analysed in detail |
| Upcoming Events | Export SOPs (US order), TREM‑V regulatory developments, Q2/Q3 earnings |
| Short-term Catalysts | Export ramp-up announcements, margin beat, order wins |
| Near-term Risks | Regulatory timing, OEM volumes, raw material moves |

**Score Reasoning:**  
- Price is above both 50/200 DMA — positive structural technicals; medium-term momentum improved substantially from March lows.  
- Volatility amplified around corporate actions (buyback / bonus / dividend).  
- Market sentiment anchored by credible cash returns and order announcements; still sensitive to OEM cycle news and regulatory timing.

#### Shareholding Pattern Analysis: 8/10

| Shareholding Pattern | Current % (Jul 2025) | Previous | Change |
|---------------------|----------------------|----------|--------|
| Promoter Holding | 64.31% | 73.20% (earlier) | - |
| FII Holding | 2.25% | ~1.5% | + |
| DII Holding | 11.43% | ~0.4% | + |
| Public Holding | 22.02% | ~24% | - |
| Pledged Shares | 0.00% | 0.00% | 0% |

| Sentiment Indicators | Assessment |
|---------------------|------------|
| Quality Investors | ICICI Prudential, HDFC MF, Nippon (notable DII names) |
| Recent Changes | Increased DII interest post FY24/25 performance |
| News Sentiment | Positive (institutional accumulation) |
| Options Activity | Neutral |

**Score Reasoning:**  
- Promoters retain controlling stake and have not pledged shares — alignment of interests.  
- Growing DII presence (multiple established funds) is a positive sign of institutional confidence.  
- FII share still modest — room for incremental inflows if export narrative strengthens.  
- No pledge and limited leverage at promoter level reduces governance risk.

## Peer Comparison Summary

| Comparison Aspect | Assessment | Explanation |
|-------------------|------------|-------------|
| **Valuation vs. Peers** | Discount on P/E, Premium on P/B | P/E ~19x vs peer median ~27x (discount); P/B ~5.6x vs median ~3.3x (premium explained by higher ROE/ROCE) |
| **Performance vs. Peers** | Superior return metrics | ROCE (~39%) and ROE (~30%) materially higher than peer medians — drives strategic premium if growth is delivered |

## Key Strengths
- High capital efficiency (ROCE ~39%, ROE ~30%) enabling high returns on incremental investments.  
- Strong liquidity: cash + investments of ~₹958 Cr and nominal financial debt — supports M&A, capex and shareholder returns.  
- Market leadership in emission control (~30% share) and growing presence in lightweighting (control arms) — differentiated product mix.  
- Clear strategic roadmap: exports (China+1), lightweighting, JV/tech tie‑ups; credible order wins for US/EU.  
- Demonstrated shareholder-friendly capital allocation (buyback, dividend, bonus) alongside reinvestment.

## Key Concerns  
- Customer concentration: two marquee customers (M&M, Hyundai) account for a very large share of exhaust revenue — single‑customer risk remains.  
- Regulatory timing uncertainty (TREM‑V/CEV/BS‑VII) — delays or changes could push revenue recognition/timing.  
- Export ramp-up execution risk: certifications, pilot orders and local tooling take time (qualification cycles 12–18 months).  
- Commodity/catalyst price pass-through and accounting can cause topline/margin volatility quarter-to-quarter.  
- Limited FII presence — stock performance dependent on domestic institutional flows.

## Scenario Analysis

### Bull Case Scenario

| Aspect | Details |
|--------|---------|
| **Assumptions** | Revenue growth +20% (next 12 months) driven by faster-than-expected export ramp (SOPs materialise); EBITDA margin expands to 16% due to higher mix of lightweighting & emission systems; EPS growth +25%. Valuation multiple expands to 24x (forward P/E) on re-rating for structural export growth. |
| **Catalysts** | Successful SOP for US $7m order (production start), strong ramp at Chakan plant, favourable TREM‑V timing, further JV/technical tie-ups, positive broker upgrades. |
| **Target Price** | ₹1,662 |
| **Probability** | 25% |
| **Justification** | Strong cash buffer, credible order wins, and proven execution increase likelihood of a material upside scenario though export qualification timelines make this non‑trivial. |

### Base Case Scenario

| Aspect | Details |
|--------|---------|
| **Assumptions** | Revenue growth +8–12% (12 months) largely from domestic content increase + gradual export contribution; EBITDA margin ~14–15%; EPS growth ~15%; market assigns ~20x forward P/E. |
| **Execution Milestones** | Export pilots convert to low-run production, Plant‑III (Chakan) ramps as per management timelines, gross profit improvements persist. |
| **Target Price** | ₹1,274 |
| **Probability** | 55% |
| **Justification** | Aligns with management guidance (moderate growth, margin improvement). Most likely path given existing orderbook, capacity and conservative market re-rating. This is our base recommendation anchor. |

### Bear Case Scenario

| Aspect | Details |
|--------|---------|
| **Assumptions** | Revenue flat or -5% (OEM weakness / regulatory delays), EBITDA margin compresses to sub‑12% because of mix and raw material/catalyst volatility; EPS down ~10%; multiple compresses to ~12x. |
| **Risk Factors** | Delay/deferral of TREM‑V/CEV implementation, slower export conversion (tariff/geopolitical shocks), sharp raw-material inflation or major customer order losses. |
| **Target Price** | ₹598 |
| **Probability** | 20% |
| **Justification** | Execution and regulatory risks can trigger rapid rerating because the stock trades on growth expectations; liquidity and cash buffers reduce likelihood of insolvency but not valuation compression. |

### Scenario Summary — Probability‑weighted Expected Return

| Scenario | Return vs CMP | Target Price | Probability | Weighted Return |
|----------|---------------|--------------|-------------|-----------------|
| **Bull Case** | +57.2% | ₹1,662 | 25% | +14.30% |
| **Base Case** | +20.4% | ₹1,274 | 55% | +11.23% |
| **Bear Case** | -43.5% | ₹598 | 20% | -8.70% |
| **Expected Return** | | | **100%** | **+16.83%** |

Probability‑weighted expected return = 0.25×(+57.18%) + 0.55×(+20.42%) + 0.20×(−43.48%) = **+16.83% over 12 months**

Most Likely Scenario: Base Case — Evidence: management guidance, recent quarter results showing margin improvement despite modest revenue growth, existing export pilot wins with realistic ramp timelines, and strong balance sheet supporting gradual scaling.

## Investment Recommendation

| Recommendation | Details |
|----------------|---------|
| **RECOMMENDATION** | BUY |
| **Strategy Type** | Staggered buy (initial core purchase followed by tranche buys on dips / as milestones achieved) |
| **Entry Price Range** | ₹980 - ₹1,130 |
| **Stop Loss** | ₹880 (for tactical positions; adjust by risk tolerance) |
| **Target Price** | ₹1,274 (12 months) — base case target |
| **Position Size** | Medium (2–5% of portfolio) — increase to Large (5–10%) if export ramps accelerate and margins sustainably improve |
| **Timeline** | 12 months (primary), monitor for 18–24 months for bull scenario realisation |

**Recommendation Reasoning:**  
- Expected return (~+16.8% probability‑weighted) exceeds the BUY threshold (≥15%).  
- Company combines strong capital efficiency (ROCE/ROE), low leverage and a sizable cash/investment buffer — lowers execution risk for capex/M&A.  
- Clear multi-pronged growth strategy (exports, lightweighting, adjacencies) with tangible early wins (US order, JV arrangements).  
- Near-term downside limited by strong liquidity and high margins; upside meaningful if export/adjacency ramps accelerate.  
- Risk-managed approach: stagger purchases and add on delivery of export SOPs / sustainable margin expansion.

## Investment Thesis

1. High capital productivity: Sharda delivers ROCE ~39% and ROE ~30%, enabling attractive returns on incremental investment and supporting shareholder returns.  
2. De-risked balance sheet: Net liquidity (~₹906 Cr) and negligible conventional borrowings provide firepower for capex, M&A or continued shareholder returns without leverage risk.  
3. Structural demand tailwinds: Emission-norm tightening and lightweighting present sustainable content-per-vehicle growth drivers; Sharda is well‑positioned in both.  
4. Growing export runway: China+1 opportunity plus specific US/EU order wins can materially increase addressable market and re-rate the stock if qualification timelines remain on track.  
5. Execution-dependent upside: Valuation is reasonable on earnings (P/E ~19x); continued delivery on margins and export scale can drive re-rating to premium multiples.

## Documents Analyzed

**Research Reports & PDFs Analyzed:**
- Q1 FY26 Investor Presentation (11 Aug 2025) — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18a7eb83-a3f1-40e1-9613-c6a3942056de.pdf  
- Q1 FY25‑26 Financial Results (8 Aug 2025) — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99de897c-d2aa-4185-a6c1-8364c4be946f.pdf  
- FY25 Consolidated Presentation / Q4 FY25 (2 May 2025) — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0929280-0103-49c2-ad5c-ef22e2416b08.pdf  
- Board Meeting Outcome (Dividend / Bonus) 24 May 2025 — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dd2fd78-1201-4d8f-9438-15441f32faaa.pdf  
- Buyback Announcement (Jun 2024) — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32750892-6183-4c6e-9316-21927cc04743.pdf  
- Plant commissioning announcement (Chakan) 21 Jun 2025 — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94665747-5eea-4e1e-9a98-7961c6ecbacc.pdf  
- Annual Report FY24 — https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6e8d084-a552-4706-beba-b4e747eee565.pdf  
- CRISIL rating updates (April – July 2025) — https://www.crisil.com (rating releases analysed)

END OF ANALYSIS